Al-Ruwishan Aiman, Amer Bushra, Salem Ahmed, Abdi Ahmed, Chimpandu Namoonga, Esa Abdelmonem, Melemenis Alexandros, Saleem Muhammad Zubair, Mathew Roselit, Gamallat Yaser
Space for Research Initiative, Research Horizons, London NW10 2PU, UK.
Department of Family Medicine, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.
Curr Issues Mol Biol. 2024 Aug 1;46(8):8340-8367. doi: 10.3390/cimb46080492.
Despite recent advancements in technology, breast cancer still poses a significant threat, often resulting in fatal consequences. While early detection and treatments have shown some promise, many breast cancer patients continue to struggle with the persistent fear of the disease returning. This fear is valid, as breast cancer cells can lay dormant for years before remerging, evading traditional treatments like a game of hide and seek. The biology of these dormant breast cancer cells presents a crucial yet poorly understood challenge in clinical settings. In this review, we aim to explore the mysterious world of dormant breast cancer cells and their significant impact on patient outcomes and prognosis. We shed light on the elusive role of the G9a enzyme and many other epigenetic factors in breast cancer recurrence, highlighting its potential as a target for eliminating dormant cancer cells and preventing disease relapse. Through this comprehensive review, we not only emphasise the urgency of unravelling the dynamics of dormant breast cancer cells to improve patient outcomes and advance personalised oncology but also provide a guide for fellow researchers. By clearly outlining the clinical and research gaps surrounding dormant breast cancer cells from a molecular perspective, we aim to inspire further exploration of this critical area, ultimately leading to improved patient care and treatment strategies.
尽管近年来技术有所进步,但乳腺癌仍然构成重大威胁,常常导致致命后果。虽然早期检测和治疗已显示出一些希望,但许多乳腺癌患者仍在持续与疾病复发的恐惧作斗争。这种恐惧是有道理的,因为乳腺癌细胞可能会潜伏数年才重新出现,像捉迷藏一样逃避传统治疗。这些休眠乳腺癌细胞的生物学特性在临床环境中是一个关键但却知之甚少的挑战。在这篇综述中,我们旨在探索休眠乳腺癌细胞的神秘世界及其对患者结局和预后的重大影响。我们阐明了G9a酶以及许多其他表观遗传因素在乳腺癌复发中难以捉摸的作用,突出了其作为消除休眠癌细胞和预防疾病复发靶点的潜力。通过这一全面综述,我们不仅强调了解开休眠乳腺癌细胞动态以改善患者结局和推进个性化肿瘤学的紧迫性,还为同行研究人员提供了指南。通过从分子角度清晰勾勒围绕休眠乳腺癌细胞的临床和研究差距,我们旨在激发对这一关键领域的进一步探索,最终实现改善患者护理和治疗策略的目标。